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Abstract: 
Farnesyl transferase (FTase) is an enzyme responsible for post-translational modification in proteins  having  a carboxy-terminal CaaX motif in 
human. It catalyzes the attachment of a lipid group in proteins of RAS superfamily, which is essential in signal transduction.  FTase has been recognized 
as an important target for anti cancer therapeutics. In this work, we performed virtual screening against FTase with entire 125 compounds from Indian 
Plant Anticancer Database using AutoDock 3.0.5 software. All compounds were docked within binding pocket containing Lys164, Tyr300, His248 and 
Tyr361 residues in crystal structure of FTase. These complexes were ranked according to their docking score, using methodology  that was shown 
to  achieve  maximum  accuracy.  Finally we got three potent  compounds  with  the  best Autodock docking Score (Vinorelbine: -21.28  Kcal/mol, 
Vincristine: -21.74 Kcal/mol and Vinblastine: -22.14 Kcal/mol) and their energy scores were better than the FTase bound co-crystallized ligand (L-
739: –7.9 kcal/mol). These three compounds belong to Vinca alkaloids were analyzed through Python Molecular Viewer for their interaction studies. It 
predicted similar orientation and binding modes for these compounds with L-739 in FTase.Thus from the complex scoring and binding ability it is 
concluded that these Vinca alkaloids could be promising inhibitors for FTase. A 2-D pharmacophore was generated for these alkaloids using LigandScout 
to confirm it. A shared feature pharmacophore was also constructed that shows four common features (one hydogen bond  Donar,  Two hydrogen bond 
Acceptor and one ionizable area)  help compounds to  interact  with  this  enzyme. 
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Background: 
Many intracellular proteins are post-translationally modified by the 
attachment of lipid through a process called farnesylation (a type of 
prenylation)  [1]. This modification process has been identified in 
numerous protein located in eukaryotic organisms, including RAS 
proteins, which plays an important role in the signal transduction pathway 
that leads to constant activation of the protein, ultimately resulting in 
uncontroll cell  proliferation [2]. The  high  prevalence  of  mutated  ras 
gene, are found in 30% of all human cancer [3]. Since the farnesylation 
of oncogenic RAS protein is required for cellular transformation; a 
promising way of interfering with RAS function seemed to be the 
inhibition of Farnesyl- Transferase (Ftase) which catalyze the formation of 
thioether linkages between the C1 atom of farnesyl (15-carbon by Ftase) 
and –SH of the cystine residue at or near the C-terminus of RAS protein 
[4]. This enzyme recognizes a common CAAX amino acid sequence 
located at C-terminus of substrate protein. In CAAX motif, C is the 
cystine residue to which farnesyl group is attached; A, A are 
aliphatic amino acids and X is the carboxyl terminal residue. Crystal 
structure of human Ftase was resolved at 2.30 Å  resolution and is a 
heterodimer consisting of 44865.4 Dalton alpha subunit & 48822.9 
Dalton beta subunit [5, 6]. Several   classes   of   compound   having   
selective Farnesyl transferase inhibitory activity have been tested in 
clinical trials for example: L778123 [7], tipifarnib [8], lonafarnib [9], FTT-
277 [10]  & L744832 [11]. The promising results in preclinical models 
were not confirmed in the clinic. Unexpectedly, tumors containing  non-
mutated RAS were also sensitive to  the Farnesyl transferase inhibitors 
(FTIs). Thus there is still a need for novel, selective and potent Ftase 
inhibitors [3].Traditional synthesis of a series of new compounds through 
high-throughput screening can be carried out at high cost and also are 
time consuming; whereas on the  other  hand,  screening small  molecule 
databasesfor   novel   compounds   represents   an   alternative process.  
Docking  various ligands to the protein of interest followed by scoring to 
reveal the strength of interaction  and  to  determine  the  affinity  of 
binding has become increasingly important in the context of drug 
discovery.Screening large databases of compounds can provide a 
feasible, alternative technique against high-throughput screening, but 
depends on the fast and accuracy of the docking algorithm  [12]. 
 
In this  paper we  made  an afford  to develop a selective & potent Ftase 
inhibitors by screening a set of compounds from Indian Plant Anticancer 
Database (InPACdb) [13] against FTase protein, with bound ligand L-739, 
750 extracted from Protein Databank, [14] by utilizing exhaustive docking 
software AutoDock 3.0.5 [15]. On the basis of Docking result a 
pharmacophore map were constructed for those compounds, which are 
having high score. 
 
Methodology: 
Receptor X-ray structure: 
The 3D coordinates of the crystal structure of Human Protein Farnesyl 
Transferase Complexed with Farnesyl diphosphate and the peptidomimetic 
inhibitor L-739, 750 (PDB code: 1JCQ) [14] was selected  as  the  receptor 
model in  flexible Docking  program.  Before  Docking  all heteroatoms 
(Farnesyl Diphosphate, acetic acid, sucrose, Zinc ion, 739) & water 
molecules are removed from Protein file 1JCQ. After removing the water 
molecule H-atom were added to protein for correct ionization and 
tautomeric states of aminoacid residues such as Asp,Ser, Glu, Arg and His. Bioinformation  Volume 5 
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Figure 1: A detailed flowchart summarizing the methodology implemented is shown. 
 
 
Figure 2: 2-D Pharmacophore model of alkaloid compound (a) Vinorelbine, (b) Vincristine, (c) Vinblastine generated by LigandScout.     
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Figure 3: Shared Feature Pharmacophore of Vinorelbine, Vincristine and Vinblastine showing four common features (one hydrogen bond Donar: green 
sphere, two hydrogen bonds Acceptor: Red sphere and one ionizable area: Blue asterisk). 
 
Active Site Analysis: 
The active site was analyzed by selecting neighbors within 3Å  around 
Ligand 739,which is already bound to the crystal structure of protein 
Farnesyl Transferase (PDB code: 1JCQ). The active site contains Lys164, 
Tyr300, His248 and Tyr361 residues. 
 
Ligand preparation: 
Indian  Plant  Anticancer Compounds Database (InPACdb) [13] is a free 
online  database  of compounds  that possess anticancer properties. These 
compounds are derived from various plant species that have an Indian 
origin. It contains 125 compounds in ready-to- dock 3D formats, available 
at the URL http://www.inpacdb.org/. Molecules in InPACdb are annotated 
by molecular property that include molecular weight, molecular formula, 
number of rotatable bonds, calculated XLogP, number of hydrogen-bond 
donors, hydrogen-bond acceptors, refractivity, Topological Polar Surface 
Area  &  Van der Waals surface area (3D).  InPACdb provides several 
search criteria such as IUPAC name, Plant name, Cancer type & 
Refractivity. 
 
Virtual Screening: 
Docking of the entire 125 anticancer compounds of  InPACdb  against 
Farnesyl Transferase protein structure was done using molecular docking 
program AutoDock v3.05 [15]. Gasteiger charges are added to the ligand 
&maximum 6  numbers of  active torsions are given to the lead 
compounds  using AutoDock Tool [16]. Kollman charges and the 
solvation term were  then  added to the  protein  structure  using  the 
same. The grid for docking calculations was centered on Lys164, Tyr300, 
His248, and Tyr361 for 1JCQ in the docking studies. An 52 × 52 × 52 3D 
affinity grid with 0.381 spacing was calculated, respectively, for each of 
the following atom types C, A (aromatic C), N, O, S, H and e by 
Autogrid 3.0.The Lamarckian genetic algorithm implemented in Autodock 
was used. Docking parameters were as follows:  10 docking trials, 
population size of 150, maximum number of energy evaluation ranges of 
25,0000, maximum number of generations is 27,000, mutation rate of 
0.02, cross-over rate of 0.8, Other docking parameters were set to the 
software’s default values. After docking, the ligands were ranked 
according to their docked energy as implemented in the AutoDock 
program. 
 
Pharmacophore Modeling: 
Three-alkaloid compounds were taken on the basis of higher scoring 
function for pharmacophore modeling, which is one of the most powerful 
techniques to classify & identify key features from a group of molecules. 
And a 3D-pharmacophore is a set of interactions (chemical features or 
functionalities) aligned in three-dimensional  space.This pharmacophore 
model will furnish a new insight to design novel molecules that can 
enhance or inhibit the function of the target and will be useful in drug 
discovery strategies [17]. LigandScout [18] was used to develop 
pharmacophore model of these  three lkaloids derived from Vinca rosea. 
Different types of chemical features for each alkaloid molecule were 
examined using feature directory from LigandScout software. By 
consolidating all the available features, five common features were used 
to generate pharmacophore: Hydrogen bond donar  
 
All these three compounds with lowest docked energy were categorize 
under vinca alkaloids [20], a class of alkaloids from the genus of 
apocynaceous woody herbs including Periwinkle.  They are some of 
the most useful antineoplastic agent. However several compounds having 
selective Farnesyl transferase inhibitory activity (L778123 [7], tipifarnib 
[8], lonafarnib [9], FTT-277 [10] & L744832 [11]) is in clinical trial but 
these compounds are not very promising in preclinical models. 
Pharmacophore map was constructed for compounds (Vinorelbine, 
Vincristine and Vinblastine) using Ligand Scout [18] which are shown in 
figure 2 (a, b, c). After that shared featured pharmacophore  of these 
compounds was generated by aligning pharmacophores and molecules 
using reference points as shown in Figure 3. 
 
Conclusion: 
Flexible docking of ligand from chemical database to receptor  is  an 
emerging approach and is extensively  used  to  reduce  cost and  time  in 
drug discovery. The approach utilized in this study is successful in finding 
three potent Ftase inhibitors from Indian Plant Anticancer  Database. 
Individually these three compounds are from group of vinca alkaloid & 
show lowest docked energy and hydrogen bonding stabilizes the 
interaction. Hydrogen bonding plays an important role for the structure and 
function of biological molecules, especially for  inhibition in  a  complex. 
Thus the result demonstrates that Vinorelbine, Vincristine and Vinblastine 
are potential inhibitor  for  Farnesyl  Transferase,  which  is  a  promising 
way of interfering with RAS function. Four shared feature pharmacophore 
(one hydrogen bond Donor, Two hydrogen bond Acceptor & one ionizable 
area) are generated using LigandScout to discover the essential features of 
ligand, which are invaluable  to examine the potential lead of Farnesyl 
Transferase. Further the work can be evaluated experimentally to study the 
receptor-ligand interactions, which would help in designing of compounds 
based on virtual screening. 
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Supplementary material: 
 
Table 1: Best Docked Anticancer Compound & its docked energy with Reference Root Mean Square Deviation 
S.No.  Alkaloid 
Compound 
Name 
 
IUPAC name 
Molecular 
formula and Mol. 
Mass 
Docked 
Energy 
(Kcal/mol) 
Ref Root 
Mean 
Square 
Deviation 
1.  Vinorelbine
  4-(acetyloxy)-6,7-didehydro-15-  ((2R, 6R, 8S)-4-ethyl-1, 3,6,7,8,9- 
hexahydro- 8-(methoxycarbonyl)- 2,6-methano- 2H-azecino(4,3- b) indol-8-
yl)-3-hydroxy- 16- methoxy-1-methyl-, methyl ester, (2beta, 3beta, 4beta, 
5alpha, 12R, 19al pha)- aspidospermidine-3- carboxylic acid 
 
C45H54N4O8 
778.932 g/mol 
-21.28 148.3 
2. Vincristine  methyl  (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4- 
[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-
diazatetracyclo[13.3.1.0 
4,12.0
5,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-
formyl-10-hydroxy-5-methoxy-8, 16-diazapentacyclo[10.6.1.0
1,9.0
2,7. 
0
16,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 
 
C46H56N4O10 
824.958 g/mol 
-21.74  128.56 
 
3.  Vinblastine
 
dimethyl (2β,3β,4β,5α,12β,19α)- 15-[(5S,9S)-5-ethyl-5-hydroxy-9- 
(methoxycarbonyl)- 1,4,5,6,7,8,9,10-octahydro-2H-3,7- 
methanoazacycloundecino[5,4-  b]indol-9-yl]-3-hydroxy-16- methoxy-1- 
methyl-6,7- didehydroaspidospermidine-3,4- dicarboxylate 
 
C46H58N4O9 
810.974 g/mol 
 
-22.14 128.56 
 
 